ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

The effectiveness and safety of the rapid titration strategy of background controlled-release oxycodone hydrochloride for patients with moderate-to-severe cancer pain: A retrospective cohort study

Feng, Weineng; Wang, Yufeng; Ran, Fengming; Mao, Yong; Zhang, Helong; Wang, Qifeng; Lin, Wen; Wang, Zhidong; Hu, Jianli; Liao, Wangjun; Zhang, Tao; Chu, Qian; Xiong, Weijie; Yi, Tienan; Yi, Jiqun; Ma, Shoucheng; Sun, Yi; Meng, Lingzhan; Liu, Chunling; Zhou, Silang; Zheng, Dengyun; Wang, Shubin; Lin, Haifeng; Fang, Wenzheng; Li, Jun; Wu, Minhui*电子科技大学; 佛山市第一人民医院; 广州中医药大学; 北京大学; 华中科技大学; 南方医科大学; 汕头大学; 兰州大学; 海南医学院; 西安交通大学; 1
Frontiers in Medicine2022-10-4DOI: 10.3389/fmed.2022.918468
1被引7阅读
引用收藏
分享

摘要

BackgroundOxycodone hydrochloride is a semisynthetic narcotic analgesic agent. This study aimed to explore optimal titration strategy of controlled-release (CR) oxycodone hydrochloride in patients with cancer pain. Methods258 patients, who used regular strong opioids (morphine and CR oxycodone hydrochloride) for cancer pain across 25 three grade class hospitals in China during January 15th 2017 to April 30th 2017, were retrospectively studied. The patients were divided into 4 groups according to treatment regimens titrated. The pain remission rate and numeric rating scale (NRS) of cancer pain was recorded at 0, 12, 24, 36, 48, 60, 72 h after opioid titration. The incidence of adverse events (AEs) with therapy were also observed. Results12 h after treatment, pain remission rate of Group B, C and D was significantly higher (P < 0.001) than Group A. For the complete remission rate, there were also significant differences among the four groups (P < 0.001). No significant difference was found among four groups for pain remission rate at 24, 72 h after treatment. Multiple comparison of NRS scores showed that the both Group B and C varied significantly with Group D (P = 0.028, P = 0.05, respectively), showing superior analgesic effect over Group D. AEs were significantly different among groups (P < 0.01), with the most frequent AEs in Group A, lowest in Group B. ConclusionThe rapid titration strategy of background CR oxycodone hydrochloride was effectiveness and safety in patients with moderate-to-severe cancer pain.

学科与关键词

关键词
immediate-release (IR) morphinecontrolled-release (CR) oxycodonecancer paindose titrationoxycodone hydrochloridepain remission
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
Frontiers in Medicine
发表日期
2022-10-04
卷期
第 9 卷
页码
918468
DOI
10.3389/fmed.2022.918468
期刊等级
3区
成果收录
SCIE
资助标注
Mundipharma (China) Pharmaceutical Co., Ltd

作者

  • F

    Feng, Weineng (第一作者)

    first peoples hosp foshan

  • W

    Wang, Yufeng

    kunming med univ

查看全部 26 位作者收起作者
  • R

    Ran, Fengming

    kunming med univ · hubei canc hosp

  • M

    Mao, Yong

    kunming med univ

  • Z

    Zhang, Helong

  • W

    Wang, Qifeng

    sichuan canc hosp & inst · uestc

  • L

    Lin, Wen

    shantou univ

  • W

    Wang, Zhidong

  • H

    Hu, Jianli

    huazhong univ sci & technol

  • L

    Liao, Wangjun

    southern med univ

  • Z

    Zhang, Tao

    1 · chongqing med univ

  • C

    Chu, Qian

    huazhong univ sci & technol

  • X

    Xiong, Weijie

  • Y

    Yi, Tienan

  • Y

    Yi, Jiqun

  • M

    Ma, Shoucheng

    1 · lanzhou univ

  • S

    Sun, Yi

  • M

    Meng, Lingzhan

    chongqing tradit chinese med hosp · chengdu univ tcm

  • L

    Liu, Chunling

  • Z

    Zhou, Silang

  • Z

    Zheng, Dengyun

    guangzhou univ chinese med

  • W

    Wang, Shubin

    peking univ

  • L

    Lin, Haifeng

    2 · hainan med univ

  • F

    Fang, Wenzheng

    pla gen hosp

  • L

    Li, Jun

    cent hosp wuhan

  • W

    Wu, Minhui (通讯)

    xi an jiao tong univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417